RI H7625/S2255 prohibits insurers from imposing cost sharing (copays or meeting a deductible) or utilization review (also referred to as utilization management), such as prior authorization or step therapy, for any HIV prevention drug.

Learn more about PrEP and how GLAD is working to expand access to this game-changing HIV prevention medication.